title: The Cost-Effectiveness Of Saxagliptin When Added To Metformin And Sulphonylurea In The Treatment Of Type 2 Diabetes Mellitus In Spain.
authors.affiliation: AstraZeneca, Madrid, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Sánchez-Covisa
authors.affiliation: EAP Raval Sud- Institut Català de la Salut - USR Barcelona ciutat - IDIAP Jordi Gol, Barcelona, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Franch
authors.affiliation: Germans Trias i Pujol University Hospital, Barcelona, Spain.
authors.forename: D
authors.initials: D
authors.lastname: Mauricio
authors.affiliation: Oblikue Consulting, Barcelona, Spain.
authors.forename: N
authors.initials: N
authors.lastname: López-Martínez
authors.affiliation: Pharmerit International, Rotterdam, The Netherlands.
authors.forename: L H
authors.initials: LH
authors.lastname: Chuang
authors.affiliation: AstraZeneca, Madrid, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Capel